Premium
Developing a multidisciplinary Young Women's Blood Disorders Program: a single‐centre approach with guidance for other centres
Author(s) -
Zia A.,
Lau M.,
Journeycake J.,
Sarode R.,
Marshall J.,
De Simone N.,
Wilson E.,
Winborn A.,
Kouides P.
Publication year - 2016
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12836
Subject(s) - medicine , specialty , multidisciplinary approach , population , health care , family medicine , pediatrics , social science , environmental health , sociology , economics , economic growth
Bleeding from the reproductive tract in women is a natural event, generally occurring with menstruation and childbirth. Women with an underlying bleeding disorder may experience heavy menstrual bleeding (HMB) and thereby, unacceptable blood loss. Up to 20% of US women with abnormal uterine bleeding and a normal gynaecological exam may have an underlying bleeding disorder corresponding to almost 2–3 million American women. These females face many obstacles in achieving optimum medical care for their problems. A haematologist may not evaluate these women as they are treated symptomatically. Recognition of an underlying bleeding disorder is not straightforward and many come to attention after serious bleeding events. Although mortality from HMB is uncommon, the true burden of HMB is its impact on health‐related quality of life. To address these issues, women with HMB require a comprehensive approach to their care. Methods These reasons compelled us to institute a multidisciplinary Young Women's Blood Disorders (YWBD) Program at our institution. Results Herein, we describe the process of developing this program involving paediatric haematology, adolescent medicine and paediatric/adolescent gynaecology, and the expertise of a laboratory coagulationist, a nutritionist and nursing professionals. We also describe our experience with patient selection, the role of each specialty in the program, our approach to testing, the coordination of care and overall management of this patient population. Lastly, we propose metrics that could be followed in justifying the support of such a program. Conclusions There is a growing need to offer comprehensive care to women with HMB and blood disorders. The YWBD program at our institution appears to be successful in delivering optimal care to young women affected with HMB.